Edition:
United Kingdom

Cara Therapeutics Inc (CARA.OQ)

CARA.OQ on NASDAQ Stock Exchange Global Market

17.98USD
19 Nov 2018
Change (% chg)

-- (--)
Prev Close
$17.98
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
217,652
52-wk High
$24.30
52-wk Low
$11.48

Latest Key Developments (Source: Significant Developments)

Cara Therapeutics Reports Q2 Loss Per Share Of $0.52
Tuesday, 7 Aug 2018 

Aug 7 (Reuters) - Cara Therapeutics Inc ::CARA THERAPEUTICS REPORTS SECOND QUARTER 2018 FINANCIAL RESULTS.Q2 LOSS PER SHARE $0.52.Q2 EARNINGS PER SHARE VIEW $-0.32 -- THOMSON REUTERS I/B/E/S.Q2 REVENUE $2.9 MILLION.  Full Article

Cara Therapeutics Announces Pricing Of $85.5 Mln Offering Of Common Stock
Thursday, 19 Jul 2018 

July 18 (Reuters) - Cara Therapeutics Inc ::CARA THERAPEUTICS ANNOUNCES PRICING OF $85.5 MILLION OFFERING OF COMMON STOCK.SAYS PUBLIC OFFERING OF 4.50 MILLION COMMON SHARES PRICED AT $19.00PER SHARE.  Full Article

Cara Therapeutics Says Offering 4.50 Mln Common Shares
Tuesday, 17 Jul 2018 

July 17 (Reuters) - Cara Therapeutics Inc ::CARA THERAPEUTICS ANNOUNCES PROPOSED OFFERING OF COMMON STOCK.SAYS OFFERING 4.50 MILLION COMMON SHARES.INTENDS TO USE NET PROCEEDS FROM UNDERWRITTEN OFFERING TO FUND ITS CLINICAL AND RESEARCH DEVELOPMENT ACTIVITIES.  Full Article

Cara Therapeutics Inc reports Q3 loss per share $0.38
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Cara Therapeutics Inc :Cara Therapeutics Inc reports third quarter 2017 financial results.Q3 loss per share $0.38.Q3 earnings per share view $-0.34 -- Thomson Reuters I/B/E/S.Cara Therapeutics Inc - expects existing cash and cash equivalents, among others to be sufficient to fund operating expenses, capex requirements into 2019​.  Full Article

Cara Therapeutics signs licensing deal with Vifor Fresenius, shares surge

Shares of Cara Therapeutics surged more than 20 percent on Wednesday after it signed a licensing agreement with Vifor Fresenius Medical Care Renal Pharma Ltd that could give the U.S. drug developer up to $470 million in milestone payments.